Optimising outcomes: Navigating the patient journey with MRI & PET PSMA
I-MED Radiology's Dr Bao (Sonny) Ho explores the critical role MRI and PET imaging play in the patient journey, from initial high PSA detection, through staging, treatment planning, ongoing surveillance, restaging and treatment response assessment.
Urology - advanced imaging and the benefits of a multidisciplinary approach
I-MED Radiology's A/Prof Nick Brown and guest speakers Dr John Yaxley and Dr Anojan Navaratnam discuss how better healthcare outcomes are achieved by medical collaboration between urology and radiology - and how advanced imaging technology, like PET PSMA and MRI, are used.
Urology and prostate imaging services at I-MED Radiology
Our urologic radiology is a subspecialised service that assists in the diagnosis and treatment of diseases or conditions such as urinary tract infections, kidney stones, bladder control problems, and prostate cancer.
PET PSMA for Prostate Cancer
July 2022 - Two new item numbers for prostate specific membrane antigen (PSMA) positron emission tomography (PET) study for patients with prostate cancer.
Multiparametric MRI of the prostate
July 2018 - New MBS Items for multiparametric magnetic resonance imaging(mpMRI) of the prostate
Diagnostic imaging pathway - Prostate Cancer
Health practitioners can reference this diagram to assist with medical imaging decisions for both suspected and staging for prostate cancer. Source: Radiology Across Borders (originally developed by Western Australia Health).
Diagnostic imaging pathway - Scrotal Mass
Health practitioners can reference this diagram to assist with their medical imaging decisions for the investigation of a scrotal mass. Source: Radiology Across Borders (originally developed by Western Australia Health).
Academic articles - cowritten by an I-MED Radiologist
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy.
Eur J Nucl Med Mol Imaging. 2022; 49(9): 3289–3294. Published online 2022 Mar 17.
Matthew J. Roberts, Andrew Morton, Nathan Papa, Anthony Franklin, Sheliyan Raveenthiran, William J. Yaxley, Geoffrey Coughlin, Troy Gianduzzo, Boon Kua, Louise McEwan, David Wong, Brett Delahunt, Lars Egevad, Hemamali Samaratunga, Nicholas Brown, Robert Parkinson, Louise Emmett, and John W. Yaxley.
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial.
AUA The Journal of Urology. Volume 208, Issue 5, November 2022, Page: 1028-1036.
Paul Doan, Matthijs J. Scheltema, Amer Amin, Ron Shnier, Bart Geboers, William Gondoputro, Daniel Moses, Pim J. van Leeuwen, Anne Maree Haynes, Jayne Matthews, Phillip Brenner, Gordon O’Neill, Carlo Yuen, Warick Delprado, Phillip Stricker, and James Thompson.
Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.
BMC Urology, 2022 Mar 2;22(1):28.
Alexandar Blazevski, William Gondoputro, Matthijs J Scheltema, Amer Amin, Bart Geboers, Daniela Barreto, Anne-Maree Haynes, Ron Shnier, Warick Delprado, Shikha Agrawal, James E Thompson, Phillip D Stricker.
Intracranial Metastasis from Prostate Cancer: Investigation, Incidence, and Imaging Findings in a Large Cohort of Australian Men.
Journal of Clinical Imaging Science, 2021;11:24.
Rhiannon McBean , Annaleis Tatkovic, David Chee Wong.